Product Code: GVR-4-68040-051-6
Dermal Fillers Market Growth & Trends:
The global dermal fillers market size is anticipated to reach USD 12.2 billion by 2030, registering a CAGR of 8.7% over the forecast period, according to the new report of Grand View Research, Inc. Dermal fillers are soft tissue injectables that are injected into different depths of the skin and assist in treating signs of aging, loss of volume, facial contouring, etc. The ever-rising demand for aesthetic treatments that are safe and effective, increasing focus on appearance, rising disposable income, and growing geriatric population are expected to boost the market growth. As per the American Society of Plastic Surgeons, dermal fillers differ in chemical makeup and longevity and have varying degrees of softness.
For example, softer fillers are used on the lips, while sturdier fillers areused to enhance cheekbones. The ASPS reported that in 2020, around 2,619,650 hyaluronic acid dermal filler treatments were carried out in the U.S, and brands like Juvederm Ultra, Juvederm Ultra Plus, Perlane, Restylane, Belotero were the most preferred.The product demand is expected to increase significantly due to the fact that it provides desired results for individuals and can also be reversed if the patient is not satisfied with the results.
Growing social media influence, high consciousness about aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the factors driving the market growth.In light of COVID-19, the market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended during the first half of 2020. However, the demand has been on the rise post-pandemic. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to boost the market growth.
Dermal Fillers Market Report Highlights:
- The hyaluronic acid dermal filler segment held the largest share and is expected to witness the highest growth rate during the forecast period
- The biodegradable type segment held the largest revenue share in 2022 as this is the most adopted filler-type product used by professionals and individuals
- The wrinkle correction application segment held the largest market share in 2022 due to an increasing focus on looking younger and treating signs of aging
- The MedSpa segment was the largest in 2022due to the fact that MedSpa provides aesthetic treatments under the supervision of a licensed medical practitioner
- North America dominated the market in 2022 due to the rising awareness about such procedures and the presence of skilled aesthetic professionals
Table of Contents
Chapter 1 Report Scope And Objectives
- 1.1 Market Segmentation & Scope
- 1.2 Regional Scope
- 1.2.1 Estimates And Forecast Timeline
- 1.3 Objectives
- 1.3.1 Objective - 1
- 1.3.2 Objective - 2
- 1.3.3 Objective - 3
Chapter 2 Methodology
- 2.1 Research Methodology
- 2.2 Information Procurement
- 2.2.1 Purchased Database
- 2.2.2 Gvr's Internal Database
- 2.2.3 Secondary Sources
- 2.2.4 Primary Research
- 2.3 Information Or Data Analysis
- 2.3.1 Data Analysis Models
- 2.4 Market Formulation & Validation
- 2.5 Model Details
- 2.5.1 Commodity Flow Analysis (Model 1)
- 2.5.2 Volume Price Analysis (Model 2)
- 2.6 List Of Secondary Sources
Chapter 3 Executive Summary
- 3.1 Market Outlook
- 3.2 Segment Outlook
- 3.2.1 Product
- 3.2.2 Type
- 3.2.3 Application
- 3.2.4 End-Use
- 3.2.5 Region
- 3.3 Competitive Insights
- 3.4 Dermal Fillers Market Outlook, 2022
Chapter 4 Market Variables, Trends & Scope
- 4.1 Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Dermal Fillers Market Dynamics
- 4.2.1 Market Driver Analysis
- 4.2.1.1 Rising Demand For Minimally Invasive Aesthetic Procedures
- 4.2.1.2 Growing Trend Of Age-Less Beauty
- 4.2.1.3 Technological Developments In Medical Aesthetic Products
- 4.2.2 Market Restraint Analysis
- 4.2.2.1 High Costs Associated To The Aesthetic Procedures
- 4.3 Dermal Fillers Market: Business Environment Analysis Tools
- 4.3.1 Porter's Five Forces Analysis
- 4.3.1.1 Threat Of New Entrants
- 4.3.1.2 Bargaining Power Of Suppliers
- 4.3.1.3 Bargaining Power Of Buyers
- 4.3.1.4 Competitive Rivalry
- 4.3.1.5 Threat Of Substitutes
- 4.3.2 Pestel Analysis
- 4.3.2.1 Political & Legal
- 4.3.2.2 Economic & Social
- 4.3.2.3 Technological
- 4.4 Penetration & Growth Prospect Mapping
- 4.5 Technology Trend Analysis
- 4.6 Regulatory Framework
- 4.7 Impact Of Covid-19 On Dermal Fillers Market
Chapter 5 Dermal Fillers Market: Product Analysis
- 5.1 Dermal Fillers Product Market Share Analysis, 2022 & 2030
- 5.2 Dermal Fillers, Product, Market: Segment Dashboard:
- 5.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Product Segment
- 5.3.1 Hyaluronic Acid
- 5.3.1.1 Hyaluronic Acid Market, 2018 - 2030 (USD Million)
- 5.3.2 Calcium Hydroxylapatite
- 5.3.2.1 Calcium Hydroxylapatite Market, 2018 - 2030 (USD Million)
- 5.3.3 Polylactic Acid (Plla)
- 5.3.3.1 Polylactic Acid (Plla) Market, 2018 - 2030 (USD Million)
- 5.3.4 Polymethyl-Methacrylate Microspheres
- 5.3.4.1 Polymethyl-Methacrylate Microspheres Market, 2018 - 2030 (USD Million)
- 5.3.5 Others
- 5.3.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Dermal Fillers Market: Type Analysis
- 6.1 Dermal Fillers Type Market Share Analysis, 2022 & 2030
- 6.2 Dermal Fillers, Type, Market: Segment Dashboard:
- 6.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Type Segment
- 6.3.1 Biodegradable
- 6.3.1.1 Biodegradable Market, 2018 - 2030 (USD Million)
- 6.3.2 Non-Biodegradable
- 6.3.2.1 Non-Biodegradable Market, 2018 - 2030 (USD Million)
Chapter 7 Dermal Fillers Market: Application Analysis
- 7.1 Dermal Fillers Application Market Share Analysis, 2022 & 2030
- 7.2 Dermal Fillers Application Market: Segment Dashboard
- 7.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For The Application Segment
- 7.3.1 Wrinkle Correction
- 7.3.1.1 Wrinkle Correction Market, 2018 - 2030 (USD Million)
- 7.3.2 Facial Contouring
- 7.3.2.1 Facial Contouring Market, 2018 - 2030 (USD Million)
- 7.3.3 Scar Treatment
- 7.3.3.1 Scar Treatment Market, 2018 - 2030 (USD Million)
- 7.3.4 Lip Enhancement
- 7.3.4.1 Lip Enhancement Market, 2018 - 2030 (USD Million)
- 7.3.5 Others
- 7.3.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 8 Dermal Fillers Market: End-Use Analysis
- 8.1 Dermal Fillers End-Use Market Share Analysis, 2022 & 2030
- 8.2 Dermal Fillers End-Use Market: Segment Dashboard
- 8.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For The End-Use Segment
- 8.3.1 Medspa
- 8.3.1.1 Medspa Market, 2018 - 2030 (USD Million)
- 8.3.2 Cosmetic Surgery Clinics
- 8.3.2.1 Cosmetic Surgery Clinics Market, 2018 - 2030 (USD Million)
- 8.3.3 Hospitals
- 8.3.3.1 Hospitals Market, 2018 - 2030 (USD Million)
Chapter 9 Dermal Fillers Market: Regional Analysis
- 9.1 Dermal Fillers Regional Market Share Analysis, 2022 & 2030
- 9.2 Regional Market Snapshot
- 9.3 North America
- 9.3.1 North America Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.3.2 U.S.
- 9.3.2.1 U.S. Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.3.3 Canada
- 9.3.3.1 Canada Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4 Europe
- 9.4.1 Europe Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.2 U.K.
- 9.4.2.1 U.K. Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.3 Germany
- 9.4.3.1 Germany Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.4 France
- 9.4.4.1 France Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.5 Italy
- 9.4.5.1 Italy Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.6 Spain
- 9.4.6.1 Spain Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.7 Denmark
- 9.4.7.1 Denmark Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.8 Sweden
- 9.4.8.1 Sweden Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.4.9 Norway
- 9.4.9.1 Norway Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.5 Asia Pacific
- 9.5.1 Asia Pacific Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.5.2 Japan
- 9.5.2.1 Japan Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.5.3 China
- 9.5.3.1 China Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.5.4 India
- 9.5.4.1 India Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.5.5 Australia
- 9.5.5.1 Australia Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.5.6 Thailand
- 9.5.6.1 Thailand Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.5.7 South Korea
- 9.5.7.1 South Korea Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.6 Latin America
- 9.6.1 Latin America Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.6.2 Brazil
- 9.6.2.1 Brazil Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.6.3 Mexico
- 9.6.3.1 Mexico Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.6.4 Argentina
- 9.6.4.1 Argentina Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.7 Middle East And Africa (Mea)
- 9.7.1 MEA Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.7.2 South Africa
- 9.7.2.1 South Africa Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.7.3 Saudi Arabia
- 9.7.3.1 Saudi Arabia Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.7.4 UAE
- 9.7.4.1 Uae Dermal Fillers Market, 2018 - 2030 (USD Million)
- 9.7.5 Kuwait
- 9.7.5.1 Kuwait Dermal Fillers Market, 2018 - 2030 (USD Million)
Chapter 10 Competitive Analysis
- 10.1 Recent Developments & Impact Analysis, By Key Market Participants
- 10.2 Company Profiles
- 10.3 Merz Pharma
- 10.3.1 Company Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Benchmarking
- 10.3.4 Strategic Initiatives
- 10.4 Suneva Medical, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Benchmarking
- 10.4.4 Strategic Initiatives
- 10.5 Medytox Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Benchmarking
- 10.5.4 Strategic Initiatives
- 10.6 Sinclair Pharma
- 10.6.1 Company Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Benchmarking
- 10.6.4 Strategic Initiatives
- 10.7 Prollenium Medical Technologies
- 10.7.1 Company Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Benchmarking
- 10.7.4 Strategic Initiatives
- 10.8 Galderma
- 10.8.1 Company Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Benchmarking
- 10.8.4 Strategic Initiatives
- 10.9 Allergan, Inc.
- 10.9.1 Company Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Benchmarking
- 10.9.4 Strategic Initiatives
- 10.10 Revance Therapeutics Inc
- 10.10.1 Company Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Benchmarking
- 10.10.4 Strategic Initiatives
- 10.11 Bioplus Co. Ltd
- 10.11.1 Company Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Benchmarking
- 10.11.4 Strategic Initiatives
- 10.12 Bioaxis Pharmaceuticals
- 10.12.1 Company Overview
- 10.12.2 Financial Performance
- 10.12.3 Product Benchmarking
- 10.12.4 Strategic Initiatives
- 10.13 Teoxane Laboratories.
- 10.13.1 Company Overview
- 10.13.2 Financial Performance
- 10.13.3 Product Benchmarking
- 10.13.4 Strategic Initiatives
- 10.14 Huadong Medicine Co., Ltd
- 10.14.1 Company Overview
- 10.14.2 Financial Performance
- 10.14.3 Product Benchmarking
- 10.14.4 Strategic Initiatives
- 10.15 Marllor Biomedical Srl
- 10.15.1 Company Overview
- 10.15.2 Financial Performance
- 10.15.3 Product Benchmarking
- 10.15.4 Strategic Initiatives